Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Types I, II and III Pleuropulmonary Blastoma (PPB)
NCT06647953Phase 3Recruiting
- Sponsor
- Children's Oncology Group
- Start
- Mar 2025
- Primary completion
- Mar 2029
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 2
01
Overview
A Phase 3 trial of topotecan liposome in Pleuropulmonary blastoma (PPB), sponsored by Children's Oncology Group. Started Mar 2025; status: recruiting.
02
Drugs
topotecan liposome
03
Conditions
Pleuropulmonary blastoma (PPB)
Beyond the preview
Go deeper on NCT06647953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06647953.